Omicron-adapted COVID-19 vaccines: Could updated shots prevent a fall wave?
Global News
The U.K. has become the first country to approve a COVID-19 booster vaccine that targets the original virus and the more contagious Omicron variant.
The COVID-19 pandemic has a new line of defence – in the form of updated vaccines after the world’s first bivalent shots were approved in the U.K. this week.
A bivalent vaccine targets two different variants of the same virus.
The new vaccines are still awaiting approval in Canada and while there is no word on when that will land, Canadian doctors are optimistic about a potential rollout.
“These updated vaccines are a phenomenal tool, but the real game-changer will be distribution,” said Dr. Omar Khan, a professor of biomedical engineering and immunology at the University of Toronto.
“As long as we can get this out to as many people across the world, this is really what’s going to slow down viral evolution and prevent a new variant,” he told Global News.
On Monday, the United Kingdom became the first country to approve the so-called bivalent vaccine by Moderna as a booster for adults.
Both Pfizer and Moderna have submitted to Health Canada applications for bivalent vaccines targeting the original variant of the virus and the Omicron BA.1 sublineage.
Those submissions are currently under review, Mark Johnson, a spokesperson for Health Canada, told Global News on Monday.